Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0100
+0.0010 (11.11%)
Mar 4, 2026, 4:10 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 33.06 million as of March 4, 2026. Its market cap has increased by 108.63% in one year.
Market Cap
33.06M
Enterprise Value
28.41M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has decreased from 39.36M to 33.06M, a decrease of -16.00%. That is a compound annual growth rate of -0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 33.06M | - |
| Dec 31, 2025 | 33.06M | 317.27% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amplia Therapeutics | 61.57M |
| Neurizon Therapeutics | 60.60M |
| EZZ Life Science Holdings | 59.04M |
| Entropy Neurodynamics | 56.54M |
| Proteomics International Laboratories | 52.86M |
| NeuroScientific Biopharmaceuticals | 33.26M |
| Argenica Therapeutics | 27.62M |
| Algorae Pharmaceuticals | 25.62M |